Anthem Biosciences Ltd. (ANTHEM): Anthem Biosciences Share Price hits fresh 52-week high at Rs 947.10
- September 2, 2026
- Posted by: Harsh Piplani
- Category: News
Anthem Biosciences Share Price is in focus after the stock rose to Rs 947.10 on 02 September 2026, up Rs 23.95 or 2.59% from the previous close of Rs 923.15. The move took the company to a fresh 52-week high of Rs 952.30 during the trading day, while market capitalisation stood at Rs 50,227.82 crore. This Anthem Biosciences Share Price update is relevant because the supplied data confirms a new yearly high and provides the exact trading range, but it does not establish a company-specific catalyst. For readers tracking Anthem Biosciences Share Price Today, the verified numbers also show an opening level of Rs 923.15 and a low of Rs 917.05.
In Anthem Biosciences Stock News, the immediate takeaway is factual rather than interpretive: the stock is trading above the previous close and near the day’s high. The stock’s current setup on NSE and BSE can therefore be read through the day’s price path, the market capitalisation, and the valuation metrics supplied in the dataset. Univest is tracking the same event as part of its live market coverage.
Anthem Biosciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 947.1 |
| Previous Close | Rs 923.15 |
| Today's Move | +Rs 23.95 (+2.59%) |
| Open | Rs 923.15 |
| High | Rs 952.3 |
| Low | Rs 917.05 |
| Turnover | Rs 2.52 crore |
| Market Capitalisation | Rs 50,227.82 crore |
Anthem Biosciences Ltd. (ANTHEM) traded at Rs 947.1 versus the previous close of Rs 923.15, a rise of 2.59%. The stock opened at Rs 923.15, reached a high of Rs 952.3 and touched a low of Rs 917.05.
Anthem Biosciences Share Price Today reflects a clear intraday move within a narrow band above the opening level. The stock opened at Rs 923.15, matched the previous close at the open, moved to a low of Rs 917.05, and then touched Rs 952.30, which is also the fresh 52-week high. It was trading at Rs 947.10 at the time of this update, leaving it Rs 23.95 above the previous close. The turnover stood at Rs 2.52 crore.
Because the supplied previous 52-week high is not included in the data, the event can be described only as a fresh 52-week high and not as a breakout against a prior yearly reference. What the numbers do show is that Anthem Biosciences Share Price stayed close to the day’s peak after moving above the previous close. For readers following Anthem Biosciences Share Price Live, the verified range for the day was Rs 917.05 to Rs 952.30.
That price path is the core of today’s Anthem Biosciences Share News. It confirms the stock was active within a defined intraday range, and it naturally leads to a review of the valuation and financial context that the market is attaching to Anthem Biosciences Share Price.
Anthem Biosciences Ltd. (ANTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 50,227.82 crore |
| P/E Ratio | 90.31x |
| P/B Ratio | 16.62x |
| ROE | 21.98% |
| ROCE | 29.62% |
| EPS | Rs 10.22 |
| Book Value Per Share | Rs 55.55 |
| Dividend Yield | 0.22% |
Anthem Biosciences Ltd. (ANTHEM) fundamental metrics show P/E 90.31x, P/B 16.62x, ROE 21.98%, ROCE 29.62%. These figures provide context only and are not a buy or sell signal.
Anthem Biosciences Ltd. has a market capitalisation of Rs 50227.82 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 90.31x, P/B at 16.62x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.98% and ROCE of 29.62%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 10.22, book value per share of Rs 55.55, dividend yield of 0.22%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.13x, median ROE of 11.78%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 90.31x |
| Benchmark Median P/E | 31.13x |
| Benchmark Average P/E | 47.87x |
| Benchmark P/E Range | 3.68x to 653.31x |
| Company P/B Ratio | 16.62x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 21.98% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 29.62% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 50,227.82 crore |
| Benchmark Median Market Cap | Rs 698.8 crore |
Anthem Biosciences Ltd. (ANTHEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 90.31x, which is above the benchmark median of 31.13x, a difference of +190.11%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Anthem Biosciences Ltd. (ANTHEM) has a ROE of 21.98%, which is above the benchmark median of 11.78%, a difference of +86.59%. Anthem Biosciences Ltd. (ANTHEM) has a ROCE of 29.62%, which is above the benchmark median of 13.61%, a difference of +117.63%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Ipca Laboratories Ltd. | IPCALAB | 50,109.12 | 38.47 | 5.94 | 15.88 | 19.41 |
| Glaxosmithkline Pharmaceuticals Ltd. | GLAXO | 51,721.36 | 47.5 | 20.13 | 48.76 | 66.79 |
| Gland Pharma Ltd. | GLAND | 47,647.32 | 41.92 | 4.45 | 10.56 | 14.96 |
| Abbott India Ltd. | ABBOTINDIA | 54,942.41 | 34.4 | 10.73 | 34.67 | 46.72 |
| Ajanta Pharma Ltd. | AJANTPHARM | 45,237.67 | 38.59 | 9.02 | 25.42 | 32.67 |
Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 90.31x compared with the displayed peer median of 38.59x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.98% compares with a peer median of 25.42% across the companies shown in the table. ROCE stood at 29.62% versus the displayed peer median of 32.67%, providing a capital-efficiency comparison. Anthem Biosciences Ltd. (ANTHEM) has a market capitalisation of Rs 50,227.82 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Anthem Biosciences
- Anthem Biosciences Share Price touched a fresh 52-week high of Rs 952.30 during the trading day.
- The stock was trading at Rs 947.10, which is Rs 23.95 above the previous close.
- Market capitalisation stood at Rs 50,227.82 crore on the supplied data.
- P/E at 90.31 and P/B at 16.62 are both above the same-industry medians.
- ROE at 21.98% and ROCE at 29.62% are both above the supplied industry medians.
About Anthem Biosciences
Anthem Biosciences Ltd. (ANTHEM) is classified in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied dataset identifies the company by NSE and BSE market context and links its stock performance to the same-industry benchmark used in this article. In this Anthem Biosciences Share Price note, the business profile is kept to verified classification only, consistent with the source data.
For Anthem Biosciences Share News and Anthem Biosciences Company News tracking, the most relevant supplied facts are the sector, industry, valuation ratios, profitability ratios and market capitalisation. Univest uses those fields to present a factual company snapshot for readers following Anthem Biosciences Share Price Today.
Frequently Asked Questions
What is Anthem Biosciences Share Price today?
Ans. Anthem Biosciences Share Price was Rs 947.10 at the time of this update, up 2.59% or Rs 23.95 from the previous close of Rs 923.15. The stock also touched Rs 952.30 during the day.
Did Anthem Biosciences Share Price hit a fresh 52-week high?
Ans. Yes. Anthem Biosciences Share Price touched Rs 952.30, which is the fresh 52-week high in the supplied data. The day’s low was Rs 917.05 and the opening level was Rs 923.15.
What is the market capitalisation of Anthem Biosciences?
Ans. Anthem Biosciences has a market capitalisation of Rs 50,227.82 crore in the supplied data. That figure places the company far above the same-industry median market cap of Rs 698.8 crore.
What does Anthem Biosciences valuation show?
Ans. Anthem Biosciences Share Price is supported by a P/E ratio of 90.31 and a P/B ratio of 16.62. Both are above the same-industry medians of 31.13 and 2.87, respectively.
How do ROE and ROCE look for Anthem Biosciences?
Ans. Anthem Biosciences reports ROE of 21.98% and ROCE of 29.62%. Both are above the supplied industry medians, which are 11.78% for ROE and 13.61% for ROCE.
What are the EPS and book value for Anthem Biosciences?
Ans. EPS is Rs 10.22 and book value is Rs 55.55. These numbers provide a direct reference for Anthem Biosciences Share Price because they show earnings per share and accounting net worth per share.
Does Anthem Biosciences pay a dividend?
Ans. The supplied dividend yield for Anthem Biosciences is 0.22%. That is a factual payout metric from the dataset and should be read alongside the stock’s current price and valuation ratios.
How does Anthem Biosciences compare with pharma peers?
Ans. Anthem Biosciences Share Price trades at a higher P/E than several listed pharma peers in the supplied set. Its ROE and ROCE are also above some peers, while a few names show higher return ratios.
Which sector and industry does Anthem Biosciences belong to?
Ans. Anthem Biosciences belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The sector snapshot compares it with 200 companies in the same industry and 285 companies in the wider sector set.
Where can I track Anthem Biosciences Share Price live?
Ans. You can track Anthem Biosciences Share Price on Univest for live updates, 52-week levels, valuation ratios and benchmark comparisons. The platform also groups Anthem Biosciences Stock News and market context in one view.
Track Anthem Biosciences Share Price on Univest
Use Anthem Biosciences Ltd. (ANTHEM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
You can track Anthem Biosciences Share Price on Univest for live price updates, fundamental ratios, 52-week levels, benchmark comparisons and market insights. Univest also brings together Anthem Biosciences Share Price Today, Anthem Biosciences Stock News and Anthem Biosciences Share Price Update in one place for easier monitoring.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
